 AUSTIN, TX DURHAM, NC, Feb. 12, 2021 GLOBE NEWSWIRE -- Shattuck Labs, Inc. Shattuck NASDAQ: STTK, a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will participate in Citis 2021 Virtual Immuno-Oncology Day Conference being held virtually February 17-18, 2021. 